{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:40:07Z","timestamp":1750005607171,"version":"3.41.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The pneumococcal conjugate vaccine has had a substantial impact on invasive pneumococcal disease. Previously, we compared immunity following vaccination with the 10-valent pneumococcal conjugate vaccine (PCV10) administered at 2 slightly different schedules: at 6 and 10 weeks of age, and at 6 and 14 weeks of age, both followed by a 9-month booster. In this study, we followed up those participants to evaluate the medium-term persistence of serotype-specific pneumococcal immunity at 2-3 years of age.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>Children from the previous studies were contacted and after taking informed consent from their parents, blood samples and nasopharyngeal swabs were collected. Serotype-specific IgG antibody concentrations were determined by enzyme-linked immunosorbent assay, for the 10 vaccine serotypes, at a WHO pneumococcal serology reference laboratory.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings:<\/jats:title>\n            <jats:p>Two hundred twenty of the 287 children who completed the primary study returned at 2\u20133 years of age to provide a blood sample and nasopharyngeal swab. The nasopharyngeal carriage rate of PCV10 serotypes in the 6\u2009+\u200914 group was higher than the 6\u2009+\u200910 group (13.4% vs. 1.9%). Nevertheless, the proportion of toddlers with serum pneumococcal serotype-specific IgG greater than or equal to 0.35 \u00b5g\/mL was comparable for all PCV10 serotypes between the 6\u2009+\u200910 week and 6\u2009+\u200914 week groups. Similarly, the geometric mean concentrations of serum pneumococcal serotype-specific IgG levels were similar in the 2 groups for all serotypes, except for serotype 19F which was 32% lower in the 6\u2009+\u200910 group than the 6\u2009+\u200914 group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Immunization with PCV10 at 6\u2009+\u200910 weeks or 6\u2009+\u200914 weeks, with a booster at 9 months in each case, results in similar persistence of serotype-specific antibody at 2-3 years of age. Thus, protection from pneumococcal disease is expected to be similar when either schedule is used.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003223","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T16:06:38Z","timestamp":1626969998000},"page":"937-943","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers"],"prefix":"10.1097","volume":"40","author":[{"given":"Meeru","family":"Gurung","sequence":"first","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev M.","family":"Bijukchhe","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Hariri","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama","family":"Kandasamy","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Thorson","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratistha","family":"Maskey","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju","family":"Pandit","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biplav","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhav Chandra","family":"Gautam","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamata","family":"Maharjan","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laxmi","family":"Lama","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baikuntha","family":"Acharya","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruby","family":"Basi","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"K.C.","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonu","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Ansari","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh P.","family":"Shah","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kelly","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine L.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"International Vaccine Access Centre, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[{"name":"Great Ormond Street Institute of Child Health Biomedical Research Centre, University College London, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic F.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"},{"name":"NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Murdoch","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Otago, Christchurch, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"},{"name":"NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrijana","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315.","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R3-20250615","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease \u2013 United States, 1998-2003.","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/339525","article-title":"Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.","volume":"185","author":"Dagan","year":"2002","journal-title":"J Infect Dis"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.","volume":"8","author":"Flasche","year":"2011","journal-title":"PLoS Med"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3126\/kumj.v9i1.6262","article-title":"Clinical profile of invasive pneumococcal disease in Patan Hospital, Nepal.","volume":"9","author":"Chhetri","year":"2011","journal-title":"Kathmandu Univ Med J"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijid.2010.05.021","article-title":"The burden of vaccine-preventable invasive bacterial infections and pneumonia in children admitted to hospital in urban Nepal.","volume":"15","author":"Kelly","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"suppl 2","key":"R8-20250615","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1086\/596490","article-title":"Invasive pneumococcal disease in Kanti Children\u2019s Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network.","volume":"48","author":"Shah","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1016\/j.vaccine.2012.03.066","article-title":"Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review.","volume":"30","author":"Jauneikaite","year":"2012","journal-title":"Vaccine"},{"key":"R10-20250615","first-page":"ii1","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.","volume":"66 Suppl 2","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/aje\/kwy219","article-title":"Association between the decline in pneumococcal disease in unimmunized adults and vaccine-derived protection against colonization in toddlers and preschool-aged children.","volume":"188","author":"Weinberger","year":"2019","journal-title":"Am J Epidemiol"},{"issue":"suppl 2","key":"R12-20250615","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/INF.0000000000000076","article-title":"Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.","volume":"33","author":"Whitney","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(15)70007-1","article-title":"Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial.","volume":"15","author":"Hamaluba","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(18)30568-1","article-title":"Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial.","volume":"19","author":"Kandasamy","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0b013e3181c67f04","article-title":"Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom.","volume":"29","author":"Goldblatt","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CVI.00289-09","article-title":"Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.","volume":"17","author":"Poolman","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","article-title":"Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group.","volume":"32","author":"Satzke","year":"2013","journal-title":"Vaccine"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/cix895","article-title":"Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries.","volume":"66","author":"Voysey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R21-20250615","first-page":"67","article-title":"PCV 10 introduction in National Immunization Program of Nepal.","volume":"8","author":"Paudel","year":"2016","journal-title":"Pediatr Infect Dis"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/21645515.2016.1241919","article-title":"Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: results from 2 long-term follow-up studies.","volume":"13","author":"Wysocki","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/archdischild-2018-316254","article-title":"Persistence of pneumococcal antibodies after primary immunisation with a polysaccharide-protein conjugate vaccine.","volume":"104","author":"Zimmermann","year":"2019","journal-title":"Arch Dis Child"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/INF.0000000000001180","article-title":"The antibody response following a booster with either a 10- or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal conjugate vaccine in early infancy.","volume":"35","author":"Tr\u00fcck","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(17)30654-0","article-title":"Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1\u2009+\u20091) compared with two primary doses and a booster (2\u2009+\u20091) in UK infants: a multicentre, parallel group randomised controlled trial.","volume":"18","author":"Goldblatt","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:01:00Z","timestamp":1750003260000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003223","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2021,7,20]]}}}